Chemical inactivation of recombinant vaccinia viruses and the effects on antigenicity and immunogenicity of recombinant simian immunodeficiency virus envelope glycoproteins

By Hulskotte E.G.J.   Dings M.E.M.   Norley S.G.   Osterhaus A.D.M.E.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1839-1845

Elsevier

Access to resources Recommend Favorite

Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection

By Nishikawa Y.   Inoue N.   Xuan X.   Nagasawa H.   Igarashi I.   Fujisaki K.   Otsuka H.   Mikami T.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1381-1390

Elsevier

Access to resources Recommend Favorite

Mechanisms of protection against simian immunodeficiency virus infection

By Johnson R.P.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1985-1987

Elsevier

Access to resources Recommend Favorite

Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles

By Li T.-C.   Suzaki Y.   Ami Y.   Dhole T.N.   Miyamura T.   Takeda N.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 370-377

Elsevier

Access to resources Recommend Favorite

Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge

By Men R.   Wyatt L.   Tokimatsu I.   Arakaki S.   Shameem G.   Elkins R.   Chanock R.   Moss B.   Lai C.-J.  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3113-3122

Elsevier

Access to resources Recommend Favorite